Nihed Draoui

Nihed Draoui currently serves as Associate Director in Oncology at Galapagos, starting in January 2023. Prior experience includes roles as Senior Research Scientist and Research Scientist in Oncology Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson from September 2018 to January 2023. Nihed Draoui was a Postdoctoral Fellow in Angiogenesis & Metabolism at VIB from April 2016 to August 2018 and held the position of Postdoctoral Experimental Officer at Cancer Research UK Manchester Institute from July 2014 to April 2016, focusing on tumor metabolism and microenvironment. Educational background includes a Bachelor's and Master's degree in Pharmacy, Pharmaceutical Sciences, followed by a PhD in Pharmaceutical & Biomedical Sciences, with a specialization in tumor metabolism and lactate transport inhibition, obtained from Université catholique de Louvain between 2004 and 2014.